Richard J. Rodgers - 13 Jul 2023 Form 3 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Director
Signature
/s/ Dennis Hom, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
13 Jul 2023
Net transactions value
$0
Form type
3
Filing time
13 Jul 2023, 21:07:43 UTC
Previous filing
16 Jun 2023
Next filing
20 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGMT Stock Option (Right to Buy) 13 Jul 2023 Common Stock 1,976 $23.05 Direct F1
holding SGMT Stock Option (Right to Buy) 13 Jul 2023 Common Stock 23,216 $6.36 Direct F1
holding SGMT Stock Option (Right to Buy) 13 Jul 2023 Common Stock 23,839 $6.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested and exercisable as of the date hereof.

Remarks:

Exhibit 24 - Power of Attorney